These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9126315)
21. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia]. Degos L Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123 [TBL] [Abstract][Full Text] [Related]
22. [Scrotum exfoliative dermatitis with ulcers associated with treatment of acute promyelocytic leukemia with all-trans retinoic acid]. Tajima K; Sagae M; Yahagi A; Akiba J; Suzuki K; Hayashi T; Satoh S Rinsho Ketsueki; 1998 Jan; 39(1):48-52. PubMed ID: 9492553 [TBL] [Abstract][Full Text] [Related]
23. [Differentiation therapy of acute promyelocytic leukemia: two successful cases of remission induction by all-trans retinoic acid]. Shimizu H; Min ZZ; Konno K; Kitano Y; Sakakibara Y; Kawai S; Fujimoto T Rinsho Ketsueki; 1992 Feb; 33(2):250-5. PubMed ID: 1635178 [TBL] [Abstract][Full Text] [Related]
24. Retinoic acid syndrome in acute promyelocytic leukemia. Sentero D; Hosenpud J Wis Med J; 1997 Apr; 96(4):35-8. PubMed ID: 9128433 [TBL] [Abstract][Full Text] [Related]
25. Induction of differentiation of retinoic acid-resistant acute promyelocytic leukemia cells by the combination of all-trans retinoic acid and granulocyte colony-stimulating factor. Higuchi T; Kizaki M; Omine M Leuk Res; 2004 May; 28(5):525-32. PubMed ID: 15068906 [TBL] [Abstract][Full Text] [Related]
26. [All-trans retinoic acid-induced myelomonocytoid differentiation in acute promyelocytic leukemia]. Mori H; Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Niikura H; Omine M; Fujita K Rinsho Ketsueki; 1997 May; 38(5):440-4. PubMed ID: 9194390 [TBL] [Abstract][Full Text] [Related]
27. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells. Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735 [TBL] [Abstract][Full Text] [Related]
28. [A third complete remission of acute promyelocytic leukemia achieved by administering a gradual increase of all-trans retinoic acid following massive ascites due to retinoic acid syndrome]. Tsujioka T; Wada H; Yata K; Suemori S; Yamada O; Sugihara T Rinsho Ketsueki; 2003 Jul; 44(7):474-6. PubMed ID: 12931568 [TBL] [Abstract][Full Text] [Related]
29. Effects of prostaglandin E2 and all-trans retinoic acid combination on induced differentiation of human acute promyelocytic leukemia NB4 cells. Chen Z; Breitman TR Chin Med J (Engl); 1997 Oct; 110(10):783-8. PubMed ID: 9642310 [TBL] [Abstract][Full Text] [Related]
30. [Sinus bradyarrhythmia during administration of all-trans retinoic acid in a patient with acute promyelocytic leukemia]. Maruhashi K; Wada H; Taniguchi M; Koizumi S Rinsho Ketsueki; 1996 May; 37(5):443-7. PubMed ID: 8691592 [TBL] [Abstract][Full Text] [Related]
32. Retinoids in the treatment of acute promyelocytic leukemia. Review of the literature. Graf N; Riesinger P; Reinhard H Klin Padiatr; 1995; 207(2):43-7. PubMed ID: 7752598 [TBL] [Abstract][Full Text] [Related]
33. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia. Quezada G; Kopp L; Estey E; Wells RJ Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388 [TBL] [Abstract][Full Text] [Related]
34. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. Hashimoto S; Koike T; Tatewaki W; Seki Y; Sato N; Azegami T; Tsukada N; Takahashi H; Kimura H; Ueno M Leukemia; 1994 Jul; 8(7):1113-5. PubMed ID: 8035603 [TBL] [Abstract][Full Text] [Related]
35. The role of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Fenaux P Acta Haematol; 1993; 89 Suppl 1():22-7. PubMed ID: 8475669 [TBL] [Abstract][Full Text] [Related]
36. Pulmonary leukostasis secondary to all-trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse. Vosburgh E Leukemia; 1992 Jun; 6(6):608-10. PubMed ID: 1602800 [TBL] [Abstract][Full Text] [Related]
37. All-trans retinoic acid in acute promyelocytic leukaemia. Avvisati G; Tallman MS Best Pract Res Clin Haematol; 2003 Sep; 16(3):419-32. PubMed ID: 12935960 [TBL] [Abstract][Full Text] [Related]
38. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy. Stentoft J; Nielsen JL; Hvidman LE Leukemia; 1994; 8 Suppl 2():S77-80. PubMed ID: 7815844 [TBL] [Abstract][Full Text] [Related]
39. The present status in all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia patients: further understanding and comprehensive strategy are required in the future. Chen ZX; Tao RF; Xia XM Leuk Lymphoma; 1992 Nov; 8(4-5):247-52. PubMed ID: 1290955 [TBL] [Abstract][Full Text] [Related]
40. Significant reduction of medical costs by differentiation therapy with all-trans retinoic acid during remission induction of newly diagnosed patients with acute promyelocytic leukemia. The Japan Adult Leukemia Study Group. Takeshita A; Sakamaki H; Miyawaki S; Kobayashi T; Kuriyama K; Yamada O; Oh H; Takenaka T; Asou N; Ohno R Cancer; 1995 Aug; 76(4):602-8. PubMed ID: 8625153 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]